Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-06-30
著者
-
ITOH Kyogo
Departments of Immunology, Kurume University School of Medicine
-
AZUMA Koichi
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of
-
Azuma Koichi
久留米大学 医学部内科学呼吸器神経膠原病内科
-
YAMADA Akira
Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy
-
Yamada Akira
久留米大学 医学部泌尿器科
-
Yamada A
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
-
Yamada Akira
Kurume University Research Center For Innovative Cancer Therapy Kurume University School Of Medicine
-
NAKAGAWA Masami
Department of Physics, Meijo University
-
KATAGIRI Kazuko
Department of Immunology, Kurume University School of Medicine
-
YAMANA Hideaki
Department of Surgery, Kurume University School of Medicine
-
Itoh K
Kurume Univ. School Of Medicine Fukuoka
-
Itoh Kyogo
久留米大学 医学部免疫学
-
AIZAWA Hisamichi
First Department of Medicine, Kurume University School of Medicine
-
Kawamura Koji
Department Of Urology Graduate School Of Medicine Chiba University
-
Azuma Koichi
Department Of Cardiorenal Medicine Yokohama City University Graduate School Of Medicien
-
Azuma Koichi
Division Of Respirology Neurology And Rheumatology Department Of Internal Medicine Kurume University
-
Itoh K
Kurume Univ. School Of Medicine Fukuoka Jpn
-
Yao Akihisa
Cancer Vaccine Development Division Research Center For Innovative Cancer Therapy And Center Of The
-
MINE Takashi
Department of Immunology, Kurume University School of Medicine
-
SHIROUZU KAZUO
Department of Surgery, Kurume University School of Medicine
-
Kunimi Kazuto
Department Of Urology Fukui Red Cross Hospital
-
Itoh K
Department Of Immunology Kurume University School Of Medicine
-
Itoh K
Departments Of Immunology Kurume University School Of Medicine
-
Itoh Kyogo
Departments Of Immunology ; Departments Of Cancer Vaccine Division Of Kurume University Research Cen
-
Itoh Kyogo
Department Of Immunology
-
Itoh Kyogo
Department Of Lmmunology Kurume University School Of Medicine
-
HIDA Naoya
Department of Immunology, Kurume University School of Medicine
-
IMAI Nobue
Department of Immunology, Kurume University School of Medicine
-
RIKIMARU Touru
First Department of Internal Medicine Kurume University School of Medicine
-
NISHIKORI Misa
Department of Immunology, Kurume University School of Medicine
-
SUKEHIRO Aki
Department of Immunology, Kurume University School of Medicine
-
HARASHIMA Nanae
Department of Immunology, Kurume University School of Medicine
-
Hida Naoya
Department Of Immunology Kurume University School Of Medicine
-
Imai Nobue
Department Of Immunology Kurume University School Of Medicine
-
Sukehiro Aki
Department Of Immunology Kurume University School Of Medicine
-
Nishikori Misa
Department Of Immunology Kurume University School Of Medicine
-
Mine Takashi
Department Of Immunology Kurume University School Of Medicine
-
Mine T
Kurume Univ. School Of Medicine Fukuoka
-
Itoh Kyogo
Cancer Vaccine Development Division Research Center For Innovative Cancer Therapy Kurume University
-
Yamana H
Department Of Surgery Kurume University School Of Medicine
-
Yamana Hideaki
Department Of Surgery Kurume University School Of Medicine
-
Harashima Nanae
Department Of Immunology Kurume University School Of Medicine
-
Yamada A
Department Of Immunology Kurume University School Of Medicine
-
Nakagawa Masami
Department Of Immunology Kurume University School Of Medicine
-
Aizawa Hisamichi
Division Of Respirology Neurology And Rheumatology Department Of Internal Medicine Kurume University
-
Aizawa Hisamichi
First Department Of Internal Medicine Kurume University
-
Komatsu Kazuto
Department Of Urology Fukui Red Cross Hospital
-
Yamada Akira
Department Of Immunology Kurume University School Of Medicine
-
Imai Nobuo
Fuji-gotemba Research Laboratories Chugai Pharmaceutical Co. Ltd.
-
Shirouzu Kazuo
Department Of Surgery Kurume University School Of Medicine
-
Shirouzu Kazuo
Department Of Surgery Kurume University
-
Kameyama Kaori
Department Of Pathology Keio University School Of Medicine
-
Katagiri Kazuko
Departments Of Immunology Kurume University School Of Medicine
-
Nakagawa Masami
Department Of Civil Engineering Tohoku University
-
Yamada Akira
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
-
Mine Takashi
Department of Applied Physics, Graduate School of Engineering, Yokohama National University, Yokohama 240-8501, Japan
-
SHIROUZU KAZUO
Department of Gastroenterology and Surgery, Kurume University School of Medicine
関連論文
- Analysis of tumor necrosis factor-α production and polymorphisms of the tumor necrosis factor-α gene in individuals with a history of Kawasaki disease
- Effects of angiotension II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy
- PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- Effect of LDL Apheresis on Atherosclerosis Goes beyond Its Cholesterol Lowering in Hemodialysis Patients : A Pilot Study
- OE-254 Overexpression of ATRAP(AT1 receptor-assosiated protein) in cardiomyocytes completely inhibits cardiac hypertrophy induced by Angiotensin(Cardiac hypertrophy, basic/clinical(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of th
- PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- Quartet Models Based on Fundamental Particles with Fractional Charge
- PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- OE-254 Overexpression of ATRAP(AT1 receptor-assosiated protein) in cardiomyocytes completely inhibits cardiac hypertrophy induced by Angiotensin(Cardiac hypertrophy, basic/clinical(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of th
- PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- Usefulness of panoramic views for novice surgeons doing retroperitoneal laparoscopic nephrectomy
- The role of testosterone in the pathogenesis of prostate cancer
- PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- OE-254 Overexpression of ATRAP(AT1 receptor-assosiated protein) in cardiomyocytes completely inhibits cardiac hypertrophy induced by Angiotensin(Cardiac hypertrophy, basic/clinical(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of th
- Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
- New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
- PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- OE-254 Overexpression of ATRAP(AT1 receptor-assosiated protein) in cardiomyocytes completely inhibits cardiac hypertrophy induced by Angiotensin(Cardiac hypertrophy, basic/clinical(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of th
- PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- Body surface area is an independent factor contributing to the effects of lamivudine treatment
- PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- PJ-643 Tissue-Specific Regulation of ATRAP, A Novel Interacting Molecule with AT1 Receptor, in Spontaneously Hypertensive Rats(Hypertension, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer
- Unusual hyperbilirubinemia associated with bacterial pneumonia and acute myeloid leukemia
- Cytokines Required for Induction of Histocompatibility Leukocyte Antigen-class I-restricted and Tumor-specific Cytotoxic T Lymphocytes by a SART1-derived Peptide
- Sequence Analysis of Genes Encoding Rodent Homologues of the Human Tumor-rejection Antigen SART-1
- Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
- A case of polymyositis complicated with interstitial pneumonitis and pneumomediastinum
- OJ-046 A Novel Modulating Effect of AT1 Receptor-Interacting Molecule on Vascular Smooth Muscle Cells(Hypertension, basic-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OE-274 A Novel Interacting Molecule with C-terminal of AT1 Receptor as a Potential Modulator of Cardiomyocyte Hypertrophy(Hypertension, basic-1 (H) OE46,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation
- Cytomegalovirus Pneumonitis Presenting Small Nodular Opacities
- Cytotoxicity Induced by Erythrina variegata Serine Proteinase Inhibitors in Tumor Hematopoietic Stem Cell Lines
- Personalized peptide vaccines : A new therapeutic modality for cancer
- Expression of Tumor-rejection Antigens in Gynecologic Cancers
- Expression of the SART-1 Antigens in Uterine Cancers
- Target molecules in specific immunotherapy against prostate cancer
- Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24^+ prostate cancer patients
- Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes from Tumor-infiltrating Lymphocytes of a Patient with Testicular Embryonal Cancer
- Expression of MAGE-1 Gene by Esophageal Carcinomas
- Histocompatibility Leukocyte Antigen-A2402-restricted Cytotoxic T Lymphocytes Recognizing Adenocarcinoma in Tumor-infiltrating Lymphocytes of Patients with Colon Cancer
- Expression of SART3 Tumor-rejection Antigen in Gastric Cancers
- Changes in the Mononuclear Cell Subpopulations of Rat Cardiac Transplant Recipients Administered FK506 for the Treatment of Ongoing Rejection
- Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients
- Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy
- Antibody Reactive to a Hepatitis C Virus (HCV)-Derived Peptide Capable of Inducing HLA-A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV-Infected Individuals without HLA-A2 Restriction
- Chemohormonal therapy as primary treatment for metastatic prostate cancer : A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist
- Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide
- Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients
- Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients
- Identification of Cyclophilin B-derived Peptides Capable of Inducing Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes
- Mouse Homologue of the Human SART3 Gene Encoding Tumor-rejection Antigen
- Detection of Circulating Tumor Cells in Patients with Prostate Cancer Using Prostate Specific Membrane-Derived Primers in the Polymerase Chain Reaction
- Spectroscopic Analysis of the Cytoagglutinating Activity of Abrin-b Isolated from Abrus precatorius Seeds against Leukemic Cells
- A GENE ENCODING SQUAMOUS CELL CARCINOMA ANTIGENS RECOGNIZED BY CYTOTOXIC T LYMPHOCYTE
- Genes Encoding Antigenic Peptides of Human Epithelial Cancers Recognized by Cytotoxic T Lymphocytes
- Detection of MAGE-4 Protein in Sera of Lung Cancer Patients
- Human Tumor Rejection Antigens MAGE1^1
- Cytokine Production by T Cells Infiltrating in the Eye of Uveitis Patients
- Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5-Aza-2'-deoxycytidine
- In Vitro Effects of Immunosuppressive Agents on Cytokine Production by HTLV-I-Infected T Cell Clones Derived from the Ocular Fluid of Patients with HTLV-I Uveitis
- Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanona antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease
- Usefulness of bronchial lavage for the diagnosis of pulmonary disease caused by Mycobacterium avium-intracellulare complex (MAC) infection
- Tuberculosis associated with gastrectomy
- High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
- Noninvasive Estimation of Aortic Blood Flow Velocty by Bioelectrical Impedance
- Bacteremic and leukopenic pneumococcal pneumonia : successful treatment with antibiotics, pulse steroid, and continuous hemodiafiltration
- Successful Bystander Cardiopulmonary Resuscitation by Chest Compression without Ventilation : A Case of the Patient with Traumatic Asphyxia
- Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2^+ glioma patients
- Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
- Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
- Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
- The Effect of Radioimmunotherapy Using Murine Monoclonal Antibody KIS1 on Esophageal Squamous Cell Carcinoma-Bearing Nude Mice
- On Analytic Solution of resonant Mixing for Solar Neutrino Oscillations
- Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients
- Acute Pulmonary Injury due to Exposure to a High Concentration of Trichloroethylene Vapor
- Acute renal failure associated with systemic capillary leak syndrome
- -0137-ACUTE AND CHRONIC EFFECTS OF CIGARETTE SMOKING ON CARDIAC AUTONOMIC FUNCTION ASSESSED BY HEART RATE SPECTRAL ANALYSIS
- The risk factors for mortality of community-acquired pneumonia in Japan
- Long-term Survival after Three-field Lymphadenectomy for an Adenocarcinoma in Barrett's Esophagus with Metastasis to Virchow's Node
- Spontaneous Regression in Small Cell Esophageal Carcinoma
- Locoregional adoptive immunotherapy resulted in regression in distant metastases of a recurrent esophageal cancer
- The singnificance of telomerase activity in cancer lesions and the noncancerous epithelium of the esophagus
- Radical Esophagectomy and Secondary Anastomosis for High-Risk Patients With Intrathoracic Esophageal Carcinoma
- Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection
- Relationship between cancer cell proliferation and thallium-201 uptake in lung cancer
- Retrospective investigation of pulmonary resection in patients with high total pulmonary vascular resistance during preoperative unilateral pulmonary artery occlusion
- Selection of Pulmonary Resection Procedures to Avoid Postoperative Complications
- Expired Gas Analysis During Exercise Testing Pre-pneumonectomy
- Preoperative Spirometry Versus Expired Gas Analysis During Exercise Testing as Predictors of Cardiopulmonary Complications After Lung Resection
- Form Factor Effect on Photodecay Processes of "ψ" Particles into a Pseudoscalar Meson in a Relativistic Composite Particle Model
- Radiative Decay Spectroscopy of Excited New Mesons Based on a Relativistic Composite Particle Model
- Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination
- Quark Number Conservation and New Particle Decays : Kaon Production in D and B Meson Decays
- Exploring immune therapy for renal cancer
- Zero Operative Mortality for Gastric Cancer with Hepatic Cirrhosis.